CPRX logo

Catalyst Pharmaceuticals (CPRX) Retained earnings

annual retained earnings:

$285.16M+$163.89M(+135.14%)
December 31, 2024

Summary

  • As of today (July 1, 2025), CPRX annual retained earnings is $285.16 million, with the most recent change of +$163.89 million (+135.14%) on December 31, 2024.
  • During the last 3 years, CPRX annual retained earnings has risen by +$311.47 million (+1183.85%).
  • CPRX annual retained earnings is now at all-time high.

Performance

CPRX Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXbalance sheet metrics

quarterly retained earnings:

$341.90M+$56.74M(+19.90%)
March 31, 2025

Summary

  • As of today (July 1, 2025), CPRX quarterly retained earnings is $341.90 million, with the most recent change of +$56.74 million (+19.90%) on March 31, 2025.
  • Over the past year, CPRX quarterly retained earnings has increased by +$197.35 million (+136.53%).
  • CPRX quarterly retained earnings is now at all-time high.

Performance

CPRX quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCPRXbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

CPRX Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+135.1%+136.5%
3 y3 years+1183.8%+2288.8%
5 y5 years+321.6%+389.1%

CPRX Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+1183.8%at high>+9999.0%
5 y5-yearat high+321.6%at high+415.2%
alltimeall timeat high+277.6%at high+312.1%

CPRX Retained earnings History

DateAnnualQuarterly
Mar 2025
-
$341.90M(+19.9%)
Dec 2024
$285.16M(+135.1%)
$285.16M(+24.4%)
Sep 2024
-
$229.22M(+23.7%)
Jun 2024
-
$185.34M(+28.2%)
Mar 2024
-
$144.55M(+19.2%)
Dec 2023
$121.27M(+143.2%)
$121.27M(+40.3%)
Sep 2023
-
$86.43M(-26.3%)
Jun 2023
-
$117.19M(+47.5%)
Mar 2023
-
$79.43M(+59.3%)
Dec 2022
$49.86M(-289.5%)
$49.86M(+104.4%)
Sep 2022
-
$24.39M(+1384.5%)
Jun 2022
-
$1.64M(-110.5%)
Mar 2022
-
-$15.62M(-40.6%)
Dec 2021
-$26.31M(-51.0%)
-$26.31M(-19.2%)
Sep 2021
-
-$32.54M(-14.0%)
Jun 2021
-
-$37.82M(-18.4%)
Mar 2021
-
-$46.34M(-13.7%)
Dec 2020
-$53.70M(-58.3%)
-$53.70M(-17.6%)
Sep 2020
-
-$65.14M(-40.0%)
Jun 2020
-
-$108.48M(-8.3%)
Mar 2020
-
-$118.26M(-8.1%)
Dec 2019
-$128.69M(-19.9%)
-$128.69M(-5.8%)
Sep 2019
-
-$136.62M(-9.1%)
Jun 2019
-
-$150.25M(-6.8%)
Mar 2019
-
-$161.21M(+0.4%)
Dec 2018
-$160.56M(+26.9%)
-$160.56M(+9.9%)
Sep 2018
-
-$146.06M(+5.7%)
Jun 2018
-
-$138.23M(+4.5%)
Mar 2018
-
-$132.26M(+4.5%)
Dec 2017
-$126.56M(+17.0%)
-$126.56M(+4.4%)
Sep 2017
-
-$121.17M(+3.6%)
Jun 2017
-
-$117.00M(+3.4%)
Mar 2017
-
-$113.12M(+4.6%)
Dec 2016
-$108.15M(+20.1%)
-$108.15M(+4.0%)
Sep 2016
-
-$103.98M(+4.0%)
Jun 2016
-
-$100.03M(+4.8%)
Mar 2016
-
-$95.46M(+6.0%)
Dec 2015
-$90.08M
-$90.08M(+6.9%)
Sep 2015
-
-$84.26M(+5.6%)
DateAnnualQuarterly
Jun 2015
-
-$79.81M(+6.1%)
Mar 2015
-
-$75.25M(+7.7%)
Dec 2014
-$69.84M(+28.5%)
-$69.84M(+5.3%)
Sep 2014
-
-$66.35M(+8.2%)
Jun 2014
-
-$61.34M(+5.5%)
Mar 2014
-
-$58.14M(+7.0%)
Dec 2013
-$54.33M(+28.8%)
-$54.33M(+2.6%)
Sep 2013
-
-$52.98M(+12.6%)
Jun 2013
-
-$47.07M(+7.2%)
Mar 2013
-
-$43.92M(+4.1%)
Dec 2012
-$42.18M(+10.7%)
-$42.18M(+0.2%)
Sep 2012
-
-$42.10M(+6.6%)
Jun 2012
-
-$39.48M(+0.7%)
Mar 2012
-
-$39.19M(+2.9%)
Dec 2011
-$38.10M(+20.2%)
-$38.10M(+6.6%)
Sep 2011
-
-$35.75M(+3.3%)
Jun 2011
-
-$34.62M(+4.2%)
Mar 2011
-
-$33.23M(+4.8%)
Dec 2010
-$31.71M(+14.5%)
-$31.71M(+2.4%)
Sep 2010
-
-$30.98M(+3.0%)
Jun 2010
-
-$30.08M(+4.6%)
Mar 2010
-
-$28.75M(+3.8%)
Dec 2009
-$27.71M(+35.4%)
-$27.71M(+4.4%)
Sep 2009
-
-$26.54M(+5.1%)
Jun 2009
-
-$25.26M(+7.5%)
Mar 2009
-
-$23.49M(+14.8%)
Dec 2008
-$20.46M(+106.7%)
-$20.46M(+22.4%)
Sep 2008
-
-$16.72M(+20.6%)
Jun 2008
-
-$13.86M(+20.7%)
Mar 2008
-
-$11.48M(+16.0%)
Dec 2007
-$9.90M(+71.9%)
-$9.90M(+10.6%)
Sep 2007
-
-$8.95M(+8.9%)
Jun 2007
-
-$8.22M(+17.2%)
Mar 2007
-
-$7.01M(+21.7%)
Dec 2006
-$5.76M(+90.1%)
-$5.76M(+14.8%)
Sep 2006
-
-$5.02M(+35.7%)
Jun 2006
-
-$3.70M(+22.0%)
Dec 2005
-$3.03M(+147.5%)
-$3.03M(+147.5%)
Dec 2004
-$1.22M
-$1.22M

FAQ

  • What is Catalyst Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for Catalyst Pharmaceuticals?
  • What is Catalyst Pharmaceuticals annual retained earnings year-on-year change?
  • What is Catalyst Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Catalyst Pharmaceuticals?
  • What is Catalyst Pharmaceuticals quarterly retained earnings year-on-year change?

What is Catalyst Pharmaceuticals annual retained earnings?

The current annual retained earnings of CPRX is $285.16M

What is the all time high annual retained earnings for Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals all-time high annual retained earnings is $285.16M

What is Catalyst Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, CPRX annual retained earnings has changed by +$163.89M (+135.14%)

What is Catalyst Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of CPRX is $341.90M

What is the all time high quarterly retained earnings for Catalyst Pharmaceuticals?

Catalyst Pharmaceuticals all-time high quarterly retained earnings is $341.90M

What is Catalyst Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, CPRX quarterly retained earnings has changed by +$197.35M (+136.53%)
On this page